The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:219-220 January 20, 1994 Number 3
NextNext

Outpatient Treatment of Febrile Children with Sickle Cell Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Wilimas, J. A.
-PubMed Citation
To the Editor: The study by Wilimas et al. (Aug. 12 issue)1 was well designed and addressed an important clinical problem. I cannot, however, agree with the authors' conclusion that intravenous ceftriaxone has been proved to be an appropriate treatment for selected febrile children with sickle cell disease. Since none of the randomized patients had sepsis, the investigators proved that outpatient ceftriaxone is an effective treatment for children without sepsis. In view of the apparent ability of the selection criteria to distinguish children with sepsis from other patients, it may be concluded that the optimal outpatient treatment for children at . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.